Authors: LEONHARDT W KURKTSCHIEV T MEISSNER D LATTKE P ABLETSHAUSER C WEIDINGER G JAROSS W HANEFELD M

Citation: W. Leonhardt et al., EFFECTS OF FLUVASTATIN THERAPY ON LIPIDS, ANTIOXIDANTS, OXIDATION OF LOW-DENSITY LIPOPROTEINS AND TRACE-METALS, European Journal of Clinical Pharmacology, 53(1), 1997, pp. 65-69

Authors: ECKEY R MENSCHIKOWSKI M LATTKE P JAROSS W

Citation: R. Eckey et al., MINIMAL OXIDATION AND STORAGE OF LOW-DENSITY LIPOPROTEINS RESULT IN AN INCREASED SUSCEPTIBILITY TO PHOSPHOLIPID HYDROLYSIS BY PHOSPHOLIPASEA(2), Atherosclerosis, 132(2), 1997, pp. 165-176

Authors: LEONHARDT W HANEFELD M MULLER G HORA C MEISSNER D LATTKE P PAETZOLD A JAROSS W SCHROEDER HE

Citation: W. Leonhardt et al., IMPACT OF CONCENTRATIONS OF GLYCATED HEMOGLOBIN, ALPHA-TOCOPHEROL, COPPER, AND MANGANESE ON OXIDATION OF LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-I DIABETES, TYPE-II DIABETES AND CONTROL SUBJECTS, Clinica chimica acta, 254(2), 1996, pp. 173-186

Authors: MENSCHIKOWSKI M LATTKE P BERGMANN S JAROSS W

Citation: M. Menschikowski et al., EXPOSURE OF MACROPHAGES TO PLA2-MODIFIED LIPOPROTEINS LEADS TO CELLULAR LIPID ACCUMULATIONS, Analytical cellular pathology, 9(2), 1995, pp. 113-121

Authors: MENSCHIKOWSKI M KASPER M LATTKE P SCHIERING A SCHIEFER S STOCKINGER H JAROSS W

Citation: M. Menschikowski et al., SECRETORY GROUP-II PHOSPHOLIPASE-A2 IN HUMAN ATHEROSCLEROTIC PLAQUES, Atherosclerosis, 118(2), 1995, pp. 173-181

Authors: MENSCHIKOWSKI M HEMPEL U DINNEBIER G LATTKE P WENZEL KW JAROSS W

Citation: M. Menschikowski et al., CHANGES IN EPITOPE EXPOSITION OF APOLIPOPROTEIN-A-I ON THE SURFACE OFHIGH-DENSITY-LIPOPROTEINS AFTER PHOSPHOLIPASE A(2) TREATMENT, Atherosclerosis, 117(2), 1995, pp. 159-167